These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2468060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
    Poncet MF, Tavernier G, Damase-Michel C, Tran MA, Berlan M, Montastruc JL, Montastruc P.
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1239-41. PubMed ID: 1659347
    [Abstract] [Full Text] [Related]

  • 3. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
    Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B.
    Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
    [Abstract] [Full Text] [Related]

  • 4. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988 Dec; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 5. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
    Morris MJ, Russell AE, Kapoor V, Cain MD, Elliott JM, West MJ, Wing LM, Chalmers JP.
    J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
    [Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects.
    Chalmers J, Morris M, Kapoor V, Cain M, Elliott J, Russell A, Pilowsky P, Minson J, West M, Wing L.
    Clin Exp Hypertens A; 1989 Oct; 11 Suppl 1():59-66. PubMed ID: 2743605
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
    Wocial B, Ignatowska-Switalska H, Pruszczyk P, Zukowska-Grójec Z, Januszewicz W.
    Mater Med Pol; 1994 Oct; 26(4):127-31. PubMed ID: 7666676
    [Abstract] [Full Text] [Related]

  • 8. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
    Hemsén A, Pernow J, Millberg BI, Lundberg JM.
    Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
    [Abstract] [Full Text] [Related]

  • 9. Splanchnic release of neuropeptide Y during prolonged exercise with and without beta-adrenoceptor blockade in healthy man.
    Ahlborg G, Lundberg JM.
    Clin Physiol; 1991 Jul; 11(4):343-51. PubMed ID: 1680600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM, Pernow J, Franco-Cereceda A, Rudehill A.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [Abstract] [Full Text] [Related]

  • 14. Circulating neuropeptide Y (NPY) and catecholamines in rat under resting and stress conditions. Arguments for extra-adrenal origin of NPY, adrenal and extra-adrenal sources of catecholamines.
    Bernet F, Dedieu JF, Laborie C, Montel V, Dupouy JP.
    Neurosci Lett; 1998 Jun 26; 250(1):45-8. PubMed ID: 9696062
    [Abstract] [Full Text] [Related]

  • 15. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
    Rudehill A, Lundberg JM, Sollevi A, Hjemdahl P.
    Acta Anaesthesiol Scand; 1987 Feb 26; 31(2):132-8. PubMed ID: 3564869
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen.
    Lundberg JM, Rudehill A, Sollevi A.
    Eur J Pharmacol; 1989 Apr 12; 163(1):103-13. PubMed ID: 2744085
    [Abstract] [Full Text] [Related]

  • 17. Phentolamine- and clonidine-induced changes in plasma neuropeptide Y-like immunoreactivity during sympathetic activation in man.
    Pernow J, Lundberg JM, Kaijser L.
    Clin Physiol; 1987 Oct 12; 7(5):431-4. PubMed ID: 2822340
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Hetland ML, Eldrup E, Bratholm P, Christensen NJ.
    Scand J Clin Lab Invest; 1991 May 12; 51(3):219-24. PubMed ID: 1909048
    [Abstract] [Full Text] [Related]

  • 20. Effects of clonidine, dihydralazine and splanchnic nerve stimulation on the release of neuropeptide Y, MET-enkephalin and catecholamines from dog adrenal medulla.
    Damase-Michel C, Tavernier G, Giraud P, Montastruc JL, Montastruc P, Tran MA.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct 12; 348(4):379-84. PubMed ID: 7904052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.